Search

everythinglearnresearchcommunity

for

Search:↓

Mice lacking a key DNA methylation enzyme in skin cells have a lower chance of activating stem cells necessary for hair growth, leading to progressive hair loss.

Aging reduces stem cell activation, leading to hair loss in mice lacking a specific enzyme.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Mother and son diagnosed with a rare genetic hair loss condition with no effective treatment.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Two mouse mutations cause similar hair loss despite different skin changes.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Hydroxychloroquine is ineffective for treating frontal fibrosing alopecia with lupus erythematosus.

The conclusion is that a systematic approach is key for treating symmetrical alopecia in dogs, but treatment may not always be necessary.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Pseudopelade is a rare inherited hair loss condition with a genetic cause.

Trichoscopy of the beard is useful for diagnosing frontal fibrosing alopecia in men.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

The absence of functional sebaceous glands causes hair follicle destruction and scarring alopecia.

Repeated botulinum toxin injections for forehead wrinkles may cause hairline recession in some women.

Deslorelin implants successfully treated hair loss in two male Keeshonden dogs.

Overexpression of a specific receptor in mice skin causes skin thinning, early skin barrier formation, eye issues, and hair loss.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Five Weimaraners had a milder form of color dilution alopecia causing hair loss and skin issues.

Two Australian Poll Hereford calves had severe anaemia, abnormal red blood cells, and skin issues.

Lymphocytic mural folliculitis in cats might be an early sign of pancreatic cancer.

Hair transplantation successfully treated hair loss in a patient with Trichorhinophalangeal syndrome.